Allison O. Taylor MD, MS

Heme/Onc + NCSP Fellowship @ Duke| @IMResidencyDuke|@GUMedicine|Health Services+ Equity Research in Myeloid Malignancies|Views are my own.🇬🇭

[Allison O. Taylor MD, MS @A_TaylorMD]

@allisonoconn Sorry for your loss. Beautiful piece.

[ECOG-ACRIN Cancer Research Group @eaonc]

Congratulations to the Spring 2026 Edith Peterson Mitchell, MD Travel Scholars! #CancerResearch #ClinicalTrials #EAOnc cc: @JackieAredoMD @jordanciuro @Jani_Chinmay @HymaPolimera @A_TaylorMD @DrMelissaSimon

[Blood Cancers Today @Blood_Cancers]

Driven by a curiosity to uncover inequities, @A_TaylorMD, of @IMResidencyDuke
@dukemedicine, set out to research on how social determinants influence hematopoietic cell transplantation outcomes.

💡 Learn more: https://t.co/t10Ntp5zUM

[Charlotte Story @The_heme_story]

So impressed at the increased support the American Society of Hematology is planning for trainees and early-career investigators!! At some point, someone invested in us. Now it’s our turn. #Fight4Hematology and secure the future of hematology research. https://t.co/q4UNAS0mVM

[Sarah Cannon Docs @SarahCannonDocs]

Honoring a legacy in oncology!
Dr. @Howard A. Burris III now has a Conquer Cancer Young Investigator Award in his name, recognizing his impact on cancer research.
Congrats to inaugural recipient Dr. Allison Taylor!
🔗 https://t.co/nITok4Nnem
#Oncology #CancerResearch #ASCO

[Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO @tomleblancMD]

Reflecting on #ASCO25 plenary presentation about #rusfertide in PV, it's wonderful to see the #patientexperience at the center of the discussion, with inclusion of #patientreportedoutcomes as key trial endpoints. Avoiding phlebotomies improves the lived experience of this chronic illness. Avoiding iron deficiency, which is the end result of ongoing therapeutic phlebotomy, improves quality of life as well. So many people living with MPNs suffer with marked symptom burden and impairments in quality of life. This new therapy will improve lives! #mpnsm #pallonc #supponc

[Conquer Cancer, the ASCO Foundation @ConquerCancerFd]

Congratulations to this year’s class of Conquer Cancer grant and award recipients! Are you one of them? Tell us in the comments! We can't wait to celebrate with you at #ASCO25. Full list of recipients: https://t.co/aE89Mrvgeu
@ASCO

[Duke Department of Medicine @dukemedicine]

New @PCORI-funded initiative at Duke integrates electronic patient-reported symptom monitoring into cancer care. Led by Drs. Thomas LeBlanc, Richard Shannon, and Michael Pignone, this project aims to improve quality of life for thousands of patients.
🔗 https://t.co/90cqqPiqNu

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE Illustrative Teaching Case: Thrombotic thrombocytopenic purpura (TTP) associated ischemic stroke has diverse clinical presentation patterns and may not always present with classical findings of anemia and thrombocytopenia. 🟣 #AHAJournals https://t.co/8YYBQfMTnE

[Stroke AHA/ASA @StrokeAHA_ASA]

@A_TaylorMD @BraydonDymm @CAMCHealth @Duke_Neurology

[ASH @ASH_hematology]

Mark your calendars! 🗓️ ASH is collaborating with the @US_FDA for a workshop on regulatory science in #hematology. Come learn about the #FDA’s role in hematology/#oncology product development and more.

Applications open March 19! Learn more: https://t.co/YoT7sYQazS

#hemeonc

[AACR @AACR]

#AACRdisp24 cochair Melissa B. Davis discussed "The Grand Challenge of Cancer Disparities: Progress, Challenges, and the Path Forward" in a keynote address to open the AACR Conference on The Science of Cancer Health Disparities.
@MeliD32

[ASH @ASH_hematology]

This week we hosted a special workshop with @FDAOncology where ASH members in academic medicine and Agency representatives learned from each other.

Want to learn more and potentially join the next one? 👉https://t.co/GcAyXSnF8G

[Duke Hematologic Malignancies & Cellular Therapy @DukeHMCT]

Top 10 tips that #PalliativeCare doctors should know when caring for patients with #MPN, featuring our faculty @LindsayReinMD and @tomleblancMD, and @DukeFellows @A_TaylorMD!

https://t.co/6WSfEIxn1Q

[National CSP @NationalCSP]

For @NCSP_Duke fellow Ceshae Harding, "NCSP provided the mentorship, time, and fostered the vocational exploration I needed to choose a career as a clinician investigator." #ApplyNCSP, @Duke_CTSI

[Duke Clinical and Translational Science Institute @Duke_CTSI]

#DukeCTSI and @NCSP_Duke are pleased to share that Allison Taylor, MD, has been selected by the @ASH_hematology to participate as one of nine outstanding fellows in the 2024 ASH Minority Hematology Fellow Award. Congratulations, Dr. Taylor!

[ASH @ASH_hematology]

"Being intentional about fostering and promoting diversity in hematology will ensure that our biggest scientific breakthroughs will be relevant to the communities we serve." #RepresentationMatters

Read more from Dr. Onwuemene: https://t.co/lbTWoINz8Q #BlackHistoryMonth

[Duke Clinical and Translational Science Institute @Duke_CTSI]

🎉 Congratulations to the members of the latest @NCSP_Duke cohort, Cassandra Dictus, PhDc, MPH, RN, & Allison Taylor, MD, MS!

Learn more about these scholars: https://t.co/CVFujT7Olr

[Allison O. Taylor MD, MS @A_TaylorMD]

Influence of Income and Education on Palliative Care in Acute Myeloid Leukemia Using the NCDB - Journal of Pain and Symptom Management https://t.co/diaeygTmMT

[Cindy M. Pabon, MD @cmpabon]

Thanks to Dr @VonettaMW for illuminating the implicit biases and discrimination experienced by URM and female oncologists. She notes the need for PDs to connect with the experience of trainees and provides solutions led by the rad onc community! #ASCOQLTY23